<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.5.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art550.dtd?><?SourceDTD.Version 5.5.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_CELREP4073 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEfx1 jpg ?><?FILEmmc1 pdf ?><?FILEmmc2 pdf ?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Rep</journal-id><journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id><journal-title-group><journal-title>Cell Reports</journal-title></journal-title-group><issn pub-type="epub">2211-1247</issn><publisher><publisher-name>Cell Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5574064</article-id><article-id pub-id-type="publisher-id">S2211-1247(17)31095-1</article-id><article-id pub-id-type="doi">10.1016/j.celrep.2017.08.007</article-id><article-categories><subj-group subj-group-type="heading"><subject>Report</subject></subj-group></article-categories><title-group><article-title>Pericytes Stimulate Oligodendrocyte Progenitor Cell Differentiation during CNS Remyelination</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>De La Fuente</surname><given-names>Alerie Guzman</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">17</xref></contrib><contrib contrib-type="author"><name><surname>Lange</surname><given-names>Simona</given-names></name><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="fn1" ref-type="fn">17</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Maria Elena</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff4" ref-type="aff">4</xref><xref rid="aff5" ref-type="aff">5</xref><xref rid="aff6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Gonzalez</surname><given-names>Ginez A.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Tempfer</surname><given-names>Herbert</given-names></name><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff7" ref-type="aff">7</xref><xref rid="aff8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name><surname>van Wijngaarden</surname><given-names>Peter</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Chao</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Di Canio</surname><given-names>Ludovica</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Trost</surname><given-names>Andrea</given-names></name><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff10" ref-type="aff">10</xref></contrib><contrib contrib-type="author"><name><surname>Bieler</surname><given-names>Lara</given-names></name><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff11" ref-type="aff">11</xref></contrib><contrib contrib-type="author"><name><surname>Zaunmair</surname><given-names>Pia</given-names></name><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff11" ref-type="aff">11</xref></contrib><contrib contrib-type="author"><name><surname>Rotheneichner</surname><given-names>Peter</given-names></name><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff11" ref-type="aff">11</xref></contrib><contrib contrib-type="author"><name><surname>O&#x02019;Sullivan</surname><given-names>Anna</given-names></name><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff11" ref-type="aff">11</xref></contrib><contrib contrib-type="author"><name><surname>Couillard-Despres</surname><given-names>Sebastien</given-names></name><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff11" ref-type="aff">11</xref></contrib><contrib contrib-type="author"><name><surname>Errea</surname><given-names>Oihana</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>M&#x000e4;e</surname><given-names>Maarja A.</given-names></name><xref rid="aff12" ref-type="aff">12</xref></contrib><contrib contrib-type="author"><name><surname>Andrae</surname><given-names>Johanna</given-names></name><xref rid="aff12" ref-type="aff">12</xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Liqun</given-names></name><xref rid="aff13" ref-type="aff">13</xref></contrib><contrib contrib-type="author"><name><surname>Keller</surname><given-names>Annika</given-names></name><xref rid="aff14" ref-type="aff">14</xref></contrib><contrib contrib-type="author"><name><surname>B&#x000e1;tiz</surname><given-names>Luis F.</given-names></name><xref rid="aff4" ref-type="aff">4</xref><xref rid="aff15" ref-type="aff">15</xref></contrib><contrib contrib-type="author"><name><surname>Betsholtz</surname><given-names>Christer</given-names></name><xref rid="aff12" ref-type="aff">12</xref><xref rid="aff16" ref-type="aff">16</xref></contrib><contrib contrib-type="author"><name><surname>Aigner</surname><given-names>Ludwig</given-names></name><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff8" ref-type="aff">8</xref><xref rid="fn2" ref-type="fn">18</xref></contrib><contrib contrib-type="author"><name><surname>Franklin</surname><given-names>Robin J.M.</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn2" ref-type="fn">18</xref></contrib><contrib contrib-type="author"><name><surname>Rivera</surname><given-names>Francisco J.</given-names></name><email>francisco.rivera@uach.cl</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff4" ref-type="aff">4</xref><xref rid="aff5" ref-type="aff">5</xref><xref rid="fn2" ref-type="fn">18</xref><xref rid="fn3" ref-type="fn">19</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Wellcome Trust and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB20AH, UK</aff><aff id="aff2"><label>2</label>Institute of Molecular Regenerative Medicine, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria</aff><aff id="aff3"><label>3</label>Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University Salzburg, 5020 Salzburg, Austria</aff><aff id="aff4"><label>4</label>Laboratory of Stem Cells and Neuroregeneration, Institute of Anatomy, Histology and Pathology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile</aff><aff id="aff5"><label>5</label>Center for Interdisciplinary Studies on the Nervous System (CISNe), Universidad Austral de Chile, Valdivia, Chile</aff><aff id="aff6"><label>6</label>Institute of Pharmacy, Faculty of Sciences, Universidad Austral de Chile, Valdivia, Chile</aff><aff id="aff7"><label>7</label>Institute for Tendon and Bone Regeneration, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria</aff><aff id="aff8"><label>8</label>Austrian Cluster for Tissue Regeneration, Vienna, Austria</aff><aff id="aff9"><label>9</label>Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Ophthalmology, Department of Surgery, University of Melbourne, Australia</aff><aff id="aff10"><label>10</label>Ophthalmology/Optometry and Research Program for Experimental Ophthalmology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria</aff><aff id="aff11"><label>11</label>Institute of Experimental Neuroregeneration, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria</aff><aff id="aff12"><label>12</label>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 751 85 Uppsala, Sweden</aff><aff id="aff13"><label>13</label>Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China</aff><aff id="aff14"><label>14</label>Division of Neurosurgery, Z&#x000fc;rich University Hospital, Z&#x000fc;rich University, 8091 Z&#x000fc;rich, Switzerland</aff><aff id="aff15"><label>15</label>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica (CIB), Facultad de Medicina, Universidad de los Andes, Santiago, Chile</aff><aff id="aff16"><label>16</label>Integrated Cardio Metabolic Center (ICMC), Karolinska Institutet Novum, 141 57 Huddinge, Sweden</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>francisco.rivera@uach.cl</email></corresp><fn id="fn1"><label>17</label><p id="ntpara0010">These authors contributed equally</p></fn><fn id="fn2"><label>18</label><p id="ntpara0015">Senior author</p></fn><fn id="fn3"><label>19</label><p id="ntpara0020">Lead Contact</p></fn></author-notes><pub-date pub-type="pmc-release"><day>22</day><month>8</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>22</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>22</day><month>8</month><year>2017</year></pub-date><volume>20</volume><issue>8</issue><fpage>1755</fpage><lpage>1764</lpage><history><date date-type="received"><day>9</day><month>5</month><year>2016</year></date><date date-type="rev-recd"><day>6</day><month>5</month><year>2017</year></date><date date-type="accepted"><day>28</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 The Authors</copyright-statement><copyright-year>2017</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="abs0010"><title>Summary</title><p>The role of the neurovascular niche in CNS myelin&#x000a0;regeneration is incompletely understood. Here, we show that, upon demyelination, CNS-resident pericytes (PCs) proliferate, and parenchymal non-vessel-associated PC-like cells (PLCs) rapidly develop. During remyelination, mature oligodendrocytes were found in close proximity to PCs. In <italic>Pdgfb</italic><sup>ret/ret</sup> mice, which have reduced PC numbers, oligodendrocyte progenitor cell (OPC) differentiation was delayed, although remyelination proceeded to completion. PC-conditioned medium accelerated and enhanced OPC differentiation in&#x000a0;vitro and increased the rate of remyelination in&#x000a0;an ex&#x000a0;vivo cerebellar slice model of demyelination. We identified Lama2 as a PC-derived factor that promotes OPC differentiation. Thus, the functional role of PCs is not restricted to vascular homeostasis but includes the modulation of adult&#x000a0;CNS progenitor cells involved in regeneration.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical Abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights" id="abs0020"><title>Highlights</title><p><list list-type="simple"><list-item id="u0010"><label>&#x02022;</label><p>CNS-resident PCs react to demyelination and are found close to differentiating OPCs</p></list-item><list-item id="u0015"><label>&#x02022;</label><p>PC-deficient mice show delayed OPC differentiation during CNS remyelination</p></list-item><list-item id="u0020"><label>&#x02022;</label><p>PC-conditioned medium accelerates OPC differentiation and enhances remyelination</p></list-item><list-item id="u0025"><label>&#x02022;</label><p>PC-derived LAMA2 induces OPC differentiation</p></list-item></list></p></abstract><abstract abstract-type="teaser" id="abs0025"><p>Following toxin-induced demyelination in PC-deficient mice and using a number of in&#x000a0;vitro approaches, Guzman de la Fuente et&#x000a0;al. show that CNS pericytes (PCs) respond to demyelination and, through Lama2 secretion, stimulate oligodendrocyte progenitor cell differentiation during remyelination. These findings extend PC function beyond vascular homeostasis toward regeneration.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>neurovascular niche</kwd><kwd>pericytes</kwd><kwd>remyelination</kwd><kwd>oligodendrocyte progenitor cell</kwd><kwd>Lama2</kwd></kwd-group></article-meta><notes><p id="misc0010">Published: August 22, 2017</p></notes></front><body><sec id="sec1"><title>Introduction</title><p>Although the adult mammalian CNS has a limited capacity for regeneration, lost oligodendrocytes and the myelin they produce are restored during remyelination. In response to demyelination, oligodendrocyte progenitor cells (OPCs) proliferate and migrate to the lesion, where they differentiate into remyelinating oligodendrocytes (<xref rid="bib9" ref-type="bibr">Franklin and Ffrench-Constant, 2008</xref>, <xref rid="bib29" ref-type="bibr">Zawadzka et&#x000a0;al., 2010</xref>). Remyelination restores saltatory conduction and ensures axonal survival, and its impairment renders demyelinated axons vulnerable to irreversible degeneration (<xref rid="bib10" ref-type="bibr">Franklin et&#x000a0;al., 2012</xref>). Thus, promoting remyelination is a major therapeutic objective in chronic demyelinating diseases such as multiple sclerosis, where remyelination becomes increasingly inefficient with disease progression (<xref rid="bib11" ref-type="bibr">Goldschmidt et&#x000a0;al., 2009</xref>).</p><p>Myelination during development is strictly coupled to angiogenesis (<xref rid="bib28" ref-type="bibr">Yuen et&#x000a0;al., 2014</xref>), where OPCs use the vasculature as scaffolds for migration (<xref rid="bib25" ref-type="bibr">Tsai et&#x000a0;al., 2016</xref>). Similarly, regeneration in the CNS is coupled to the vascular niche (<xref rid="bib19" ref-type="bibr">Manavski et&#x000a0;al., 2014</xref>). The CNS vascular niche consists of endothelial cells (ECs), vasculature-associated cells such as perivascular cells, astrocytes, neurons, OPCs, molecules derived from these cells, and blood-derived elements. Pericytes (PCs), which are located at the abluminal surface of capillaries and embedded within the basement membrane, regulate angiogenesis and neovascularization and control microvascular blood flow (<xref rid="bib2" ref-type="bibr">Armulik et&#x000a0;al., 2010</xref>). The CNS contains the highest PC density in the body, ensuring proper blood-brain barrier (BBB) structure and function (<xref rid="bib2" ref-type="bibr">Armulik et&#x000a0;al., 2010</xref>, <xref rid="bib26" ref-type="bibr">Winkler et&#x000a0;al., 2011</xref>). CNS-resident PCs also share features with mesenchymal stem cells (MSCs), expressing similar genes and differentiating into cells of the mesenchymal lineage in&#x000a0;vitro (<xref rid="bib7" ref-type="bibr">Crisan et&#x000a0;al., 2008</xref>). MSCs secrete a plethora of paracrine signaling molecules (<xref rid="bib4" ref-type="bibr">Chen et&#x000a0;al., 2009</xref>), including factors that promote oligodendrocyte differentiation (<xref rid="bib14" ref-type="bibr">Jadasz et&#x000a0;al., 2013</xref>, <xref rid="bib24" ref-type="bibr">Rivera et&#x000a0;al., 2006</xref>). We hypothesized that PCs act in a similar fashion (<xref rid="bib15" ref-type="bibr">Lange et&#x000a0;al., 2013</xref>). This assumption is supported by the close physical proximity between PCs and OPCs in healthy cerebral white matter (<xref rid="bib18" ref-type="bibr">Maki et&#x000a0;al., 2015</xref>) and by the ability of PC-derived transforming growth factor &#x003b2; 1 to regulate OPC migration during cortical development (<xref rid="bib5" ref-type="bibr">Choe et&#x000a0;al., 2014</xref>). Here we analyzed PCs, their response to a demyelinating lesion, and their functional role in oligodendrocyte differentiation during remyelination. In&#x000a0;vivo relevance was studied through a genetic mouse model with reduced pericyte coverage. Moreover, molecular and cellular analysis identified the PC-derived factor modulating OPC differentiation.</p></sec><sec id="sec2"><title>Results</title><sec id="sec2.1"><title>Pericytes Respond to CNS Demyelination</title><p>We first analyzed the proliferative response and localization of ECs and PCs following induction of white matter demyelination upon injection of ethidium bromide into the caudal cerebellar peduncles (CCPs) of adult rats (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A). In this model, demyelination occurs within 24&#x000a0;hr of injection and induces OPC proliferation and migration, which peaks at 5&#x000a0;days post-lesion induction (dpl), followed by OPC differentiation, which is ongoing at 14&#x000a0;dpl. Remyelination is completed by 21 dpl. There was a significant increase in proliferating (Ki67-positive) rat endothelial cell antigen 1&#x000a0;(RECA-1)-expressing ECs and a robust proliferative response of platelet-derived growth factor receptor beta (PDGFRb)-expressing PCs within the demyelinated lesion at 5&#x000a0;dpl (<xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref>C and S1D), although the vessel area was not altered between 5 and 21 dpl (<xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref>A and S1B). In the normal-appearing white matter (NAWM), PCs are restricted to&#x000a0;the perivascular region (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>B). The total number of PDGFRb+ cells within the lesion was significantly increased at 14 dpl compared with NAWM (<xref rid="fig1" ref-type="fig">Figures 1</xref>C and 1D). This was accompanied by the appearance of PDGFRb+ cells away from blood vessels, which, because we cannot be certain of their origin, we defined as pericyte-like cells (PLCs) to distinguish them from PCs close to blood vessels (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C). Within the whole PDGFRb+ population (i.e., PCs and PLCs), the proportion of PCs declined during remyelination (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>E), whereas the percentage of parenchymal PLCs increased and was highest at 14 dpl (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>F). Consistent with the unaltered density of ECs and PCs during remyelination (<xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref>E and S1F), the EC:PC ratio, crucial for BBB stability (<xref rid="bib2" ref-type="bibr">Armulik et&#x000a0;al., 2010</xref>), remained the same (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>G). At 5 dpl, there were numerous Ki67+ PDGFRb+ cells in the lesion that peaked at 14 dpl but declined thereafter and were absent at 60&#x000a0;dpl (<xref rid="fig1" ref-type="fig">Figures 1</xref>H&#x02013;1K). By 60 dpl, when the lesion is fully remyelinated, PDGFRb+ cell numbers and localization were similar to that in NAWM, where only PCs and no PLCs were found (<xref rid="fig1" ref-type="fig">Figures 1</xref>C&#x02013;1G). Staining for desmin, another PC marker, supported these findings (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>A).<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Pericytes React to Demyelination</p><p>(A) Ethidium bromide-induced demyelinated lesion in the CCP of adult rats.</p><p>(B) PDGFRb expressing PC and RECA-1+ ECs in NAWM.</p><p>(C) Proliferating PDGFRb+ cells and ECs (PDGFRb/RECA-1/Ki67) within lesions at 5, 14, and 21 dpl. White arrows indicate proliferating PCs and yellow arrowheads PLCs.</p><p>(D&#x02013;K) Quantitative analyses of different PC parameters in response to demyelination.</p><p>(L) Immunohistochemistry showing the distance of OPCs (Olig2+/APC&#x02212;), mature oligodendrocytes (Olig2+/APC+), and PDGFRb+ at 14 dpl; yellow arrowheads indicate OPCs and white arrows mature oligodendrocytes. The high-magnification image shows mature oligodendrocytes close to PDGFRb+ cells.</p><p>(M) The graph displays the distance distribution of OPCs and mature oligodendrocytes from PDGFRb&#x000a0;+ cells.</p><p>(C&#x02013;M) 3 or more animals were analyzed for each time point.</p><p>(L and M) 150 or more distance measurements were performed from oligodendrocytes to PDGFRb+ cells per animal.</p><p>Means &#x000b1; SEM are shown. Data were analyzed by one-way ANOVA followed by Tukey&#x02019;s post hoc test, Student&#x02019;s t test, or chi-square test. <sup>&#x02217;</sup>p&#x000a0;&#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.01, <sup>&#x02217;&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.001. Scale bars, (B) 20&#x000a0;&#x003bc;m; (C) 50&#x000a0;&#x003bc;m; (D) 50&#x000a0;&#x003bc;m, high-magnification 10&#x000a0;&#x003bc;m; (E) 50&#x000a0;&#x003bc;m, high magnification 10&#x000a0;&#x003bc;m.</p></caption><graphic xlink:href="gr1"/></fig></p><p>We hypothesized that, if PCs and/or PLCs were involved in the differentiation of OPCs into remyelinating oligodendrocytes, then the differentiated cells would tend to be located in close proximity to PDGFRb+ cells. We therefore assessed the distance between Olig2+/adenomatous polyposis coli (APC)&#x02212; OPCs and Olig2+/APC+ oligodendrocytes to the nearest PDGFRb+ cell at 14 dpl. We found that oligodendrocytes were preferentially located close (i.e., within 10&#x000a0;&#x003bc;m) to PCs, whereas OPCs showed no preferential clustering close to these cells; neither was there clustering of either OPCs or oligodendrocytes close to PLCs (<xref rid="fig1" ref-type="fig">Figures 1</xref>L and 1M; <xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref>G and S1H). These results suggest that PCs and PLCs may have differential roles in modulating OPC function during remyelination.</p></sec><sec id="sec2.2"><title>Impaired Oligodendrocyte Differentiation during Remyelination in PC-Deficient Mice</title><p>To determine whether CNS-resident PCs influence remyelination, we used <italic>Pdgfb</italic><sup>ret/ret</sup> mice, in which a mutation in the retention motif of the <italic>Pdgfb</italic> gene causes a 75%&#x02013;85% reduction in capillary PC coverage compared with heterozygous littermates (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A; <xref rid="bib2" ref-type="bibr">Armulik et&#x000a0;al., 2010</xref>, <xref rid="bib17" ref-type="bibr">Lindblom et&#x000a0;al., 2003</xref>). PDGFRb is still expressed in these mice and can still be used as a marker for residual pericytes.<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>OPC Differentiation Is affected during Remyelination in <italic>Pdgfb</italic><sup>ret/ret</sup> Mice</p><p>(A and B) Illustrations of decreased PC coverage in <italic>Pdgfb</italic><sup>ret/ret</sup> mice (A) and of lysolecithin-induced demyelination (B).</p><p>(C and J) Mature oligodendrocytes (Olig2+/APC+) and OPCs (Olig2+/APC&#x02212;) in lesions of control and <italic>Pdgfb</italic><sup>ret/ret</sup> mice at 14 dpl (C) and 21dpl (J).</p><p>(D&#x02013;G and K&#x02013;N) Quantitative analyses of oligodendroglia at 14 dpl (D&#x02013;G) and 21 dpl (K&#x02013;N).</p><p>(H and I) In situ hybridization and quantification for PLP of control and <italic>Pdg</italic>fb<sup>ret/ret</sup> mice at 14 dpl.</p><p>(O and P) Toluidine blue staining of remyelination in control and <italic>Pdgfb</italic><sup>ret/ret</sup> mice at 21 dpl (O) and its quantification by relative ranking analysis (P).</p><p>Means &#x000b1; SEM are shown. Data were analyzed by Student&#x02019;s t test or Mann-Whitney <italic>U</italic> test. <sup>&#x02217;</sup>p&#x000a0;&#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.01, <sup>&#x02217;&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.001. Scale bars, 100&#x000a0;&#x003bc;m.</p></caption><graphic xlink:href="gr2"/></fig></p><p>We first examined myelination in <italic>Pdgfb</italic><sup>ret/ret</sup> mice and found that, on post-natal day 12 (P12), the density of mature oligodendrocytes (Olig2+/APC+) was lower and the density of OPCs (Olig2+/APC&#x02212;) higher than in control mice. However, on P17, no differences were observed in OPC differentiation and myelination (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>).</p><p>Following lysolecithin-induced demyelination in the ventral spinal cord white matter (WM), the number of PDGFRb+ increased substantially in both <italic>Pdgfb</italic><sup>ret/ret</sup> and control mice. The number of PDGFRb+ cells in <italic>Pdgfb</italic><sup>ret/ret</sup> mice at 5 dpl was less than in control mice, and there were fewer PLCs. However, by 14 dpl, the density of PDGFRb+ cells was the same in both groups because of a higher proliferative response of these cells in the <italic>Pdgfb</italic><sup>ret/ret</sup> mice (<xref rid="mmc1" ref-type="supplementary-material">Figures S3</xref>A&#x02013;S3F). No differences were detected in the astrocyte or in the macrophage/microglial response between <italic>Pdgfb</italic><sup>ret/ret</sup> mice and control mice (<xref rid="mmc1" ref-type="supplementary-material">Figures S3</xref>G&#x02013;S3I). Microglia/macrophages showed the same pro-inflammatory and anti-inflammatory cell profile distribution in both groups (<xref rid="mmc1" ref-type="supplementary-material">Figures S3</xref>J&#x02013;S3L), and no differences were detected in BBB stability in the lesion area (<xref rid="mmc1" ref-type="supplementary-material">Figures S3</xref>M&#x02013;S3Q).</p><p>The total number of Olig2+ cells within the lesion was reduced in <italic>Pdgfb</italic><sup>ret/ret</sup> mice compared with controls at 14 dpl. There was no significant difference in the number of Olig2+/APC&#x02212; OPCs between <italic>Pdgfb</italic><sup>ret/ret</sup> and control mice (<xref rid="fig2" ref-type="fig">Figures 2</xref>C and 2E). However, the number of Olig2+/APC+ mature oligodendrocytes was significantly reduced in <italic>Pdgfb</italic><sup>ret/ret</sup>mice (<xref rid="fig2" ref-type="fig">Figures 2</xref>C, 2F, and 2G). In situ hybridization for proteolipid protein (PLP), a major myelin component, generated consistent results (<xref rid="fig2" ref-type="fig">Figures 2</xref>H and 2I). However, the densities of Olig2+ cells and Olig2+APC+ oligodendrocytes were the same in both groups by 21 dpl (<xref rid="fig2" ref-type="fig">Figures 2</xref>J&#x02013;2N). No differences were detected in the extent of remyelination, as assessed by ranking analysis of toluidine blue-stained resin sections in which demyelinated and remyelinated axons were discernable (<xref rid="fig2" ref-type="fig">Figures 2</xref>O and 2P).</p><p>These data indicate that <italic>Pdgfb</italic><sup>ret/ret</sup> mice show a delay in OPC differentiation because of the decreased numbers of PDGFRb+ cells at the earlier stages following demyelination. However, because the PDGFRb+ cell numbers normalize by 14 dpl, this delay does not translate into a decrease in remyelination.</p></sec><sec id="sec2.3"><title>PCs Promote OPC Differentiation and Enhance Remyelination Ex&#x000a0;Vivo</title><p>We next examined how PCs might directly influence OPC function. We therefore exposed cultured OPCs to PC-conditioned medium (PC-CM) and evaluated the rate of differentiation. MSC-conditioned medium (MSC-CM), previously identified as a strong inducer of OPC differentiation (<xref rid="bib14" ref-type="bibr">Jadasz et&#x000a0;al., 2013</xref>), was used as a positive control. Primary PCs exhibiting MSCs features, including mesenchymal differentiation potential, were isolated from adult rat brains (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A; <xref rid="mmc1" ref-type="supplementary-material">Figures S4</xref>B&#x02013;S4D). Upon incubation with PC-CM, a higher proportion of OPCs had acquired 2',3&#x02032;-cyclic-nucleotide 3&#x02032;-phosphodiesterase (CNP) and myelin basic protein (MBP) expression at 2&#x000a0;days in&#x000a0;vitro (DIV) compared with those exposed to non-conditioned control medium (<xref rid="fig3" ref-type="fig">Figures 3</xref>B&#x02013;3D). We also found a significantly higher proportion of NG2+/Olig2+ OPCs in the PC-CM-treated cultures (<xref rid="fig3" ref-type="fig">Figures 3</xref>B and 3E). This effect was likely due to an anti-apoptotic effect of the PC-CM because PC-CM significantly decreased the proportion of caspase-3-positive OPCs compared with control conditions (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>F). Proliferation, assessed by Ki67 staining, was not affected by PC-CM (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>G).<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>PCs Promote OPC Differentiation and Accelerate Remyelination in Demyelinated Organotypic Slices</p><p>(A) Schematic of the experimental design.</p><p>(B&#x02013;E) Fluorescence images (B) displaying CNP+/Olig2+, MBP+/Olig2+, and NG2+/Olig2+ oligodendrocytes at 4 DIV and their respective graphs (C&#x02013;E).</p><p>(F and G) PC-CM increases the generation of oligodendrocytes from OPCs. Graphs display (F) the OPC survival rate (NG2+/Caspase+) and (G) the OPC proliferation rate (NG2+/Ki67+) under different conditions.</p><p>(H) Illustration of lysolecithin-induced demyelination of slice cultures.</p><p>(I) Images showing axons (NFH+) and myelin (MBP+) of remyelinating cerebellar slices exposed to control medium versus PC-CM at 4, 6, and 8&#x000a0;days post lysolecithin treatment.</p><p>(J) Quantification of the MBP/NFH ratio shows that PC-CM increases the remyelination rate. 3 or more independent OPC and slice preparations were used.</p><p>Means &#x000b1; SEM are shown. Data were analyzed by two-way ANOVA followed by Bonferroni&#x02019;s post hoc test. <sup>&#x02217;</sup>p&#x000a0;&#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.01, <sup>&#x02217;&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.001. <sup>&#x02217;</sup> indicates statistical difference for PC-CM and # for MSC-CM. Scale bars, (B) 100&#x000a0;&#x003bc;m and (I) 50&#x000a0;&#x003bc;m.</p></caption><graphic xlink:href="gr3"/></fig></p><p>We next examined whether PCs can enhance remyelination. We used postnatal rat-derived cerebellar organotypic slice cultures as an ex&#x000a0;vivo model of remyelination (<xref rid="bib27" ref-type="bibr">Yuen et&#x000a0;al., 2013</xref>, <xref rid="bib30" ref-type="bibr">Zhang et&#x000a0;al., 2011</xref>). In this model, P10 rat cerebellar slices were demyelinated using lysolecithin (<xref rid="bib3" ref-type="bibr">Birgbauer et&#x000a0;al., 2004</xref>) and then exposed to PC-CM or control medium (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>H). Remyelination was analyzed at 0, 2, 4, 6, and 8&#x000a0;days after lysolecithin treatment by immunohistochemical staining for MBP and neurofilament heavy chain (NFH). PC-CM significantly enhanced the remyelination rate after lysolecithin-induced demyelination (<xref rid="fig3" ref-type="fig">Figures 3</xref>I and 3J).</p></sec><sec id="sec2.4"><title>PC-Induced OPC Differentiation Is Mediated through Lama2</title><p>We have previously shown that Lama2 mRNA expression is decreased in the microvessels of <italic>Pdgfb</italic><sup>ret/ret</sup> mice compared with control mice (<xref rid="bib2" ref-type="bibr">Armulik et&#x000a0;al., 2010</xref>; <xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>B). The <italic>Lama2</italic> gene product is highly expressed during remyelination (<xref rid="bib31" ref-type="bibr">Zhao et&#x000a0;al., 2009</xref>) and has been shown to modulate OPC function (<xref rid="bib23" ref-type="bibr">Relucio et&#x000a0;al., 2012</xref>). Given that the main source of Lama2 within the microvessels is PDGFRb+ cells, as shown by RNA sequencing (RNA-seq) (<xref rid="bib13" ref-type="bibr">He et&#x000a0;al., 2016</xref>; <xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A), we investigated whether Lama2 is a mediator of the PC-induced effect on OPC differentiation. RNA in&#x000a0;situ hybridization of healthy brain sections revealed a specific expression of Lama2 in cells expressing the PC markers PDGFRb and CD13 (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>D). In control mice, Lama2 was mainly detected around cell bodies and processes of PCs, whereas <italic>Pdgfb</italic><sup>ret/ret</sup> mice had less Lama2 protein expression that, when present, was always associated with residual PCs (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>E). Cultured PCs also expressed Lama2 (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>C). Pre-incubation of PC-CM with an anti-Lama2 antibody resulted in a significant decrease in the Olig2+/CNP+ and Olig2+/MBP+ populations compared with PC-CM pre-incubated with a general immunoglobulin G (IgG), reducing OPC differentiation to a level indistinguishable from control conditions (<xref rid="fig4" ref-type="fig">Figures 4</xref>F and 4G). These results were replicated in OPCs exposed to PC-CM harvested from PCs treated with either non-targeting or Lama2 small interfering RNA (siRNA) for 48&#x000a0;hr (<xref rid="fig4" ref-type="fig">Figures 4</xref>H and 4I). Taken together, these data identify Lama2 as a PC-derived molecule that promotes OPC differentiation.<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>PC-Derived Lama2 Promotes OPC Differentiation and Is Decreased in <italic>Pdgfb</italic><sup>ret/ret</sup> Mice</p><p>(A) RNA-seq data showing the expression of Lama2 in the microvasculature (mainly consisting of a majority of ECs with very low PC contribution) versus sorted PCs (data extracted from <xref rid="bib13" ref-type="bibr">He et&#x000a0;al., 2016</xref>).</p><p>(B) Downregulation of Lama2 in microvessels of <italic>Pdgfb</italic><sup>ret/ret</sup> mice (Affymetrix array data extracted from <xref rid="bib13" ref-type="bibr">He et&#x000a0;al., 2016</xref>).</p><p>(C) Western blot image indicating Lama2 expressed by PCs in&#x000a0;vivo (brain) and in&#x000a0;vitro.</p><p>(D) RNA in&#x000a0;situ hybridization images showing PC-specific expression of PDGFRb, CD13, and Lama2.</p><p>(E) Confocal images of CD31/PDGFRb-GFP/Lama2/desmin of <italic>Pdgfb</italic><sup>ret/+</sup> &#x000d7; <italic>Pdgfrb</italic>-EGFP mice compared with <italic>Pdgfb</italic><sup>ret/ret</sup> &#x000d7; <italic>Pdgfrb</italic>-EGFP indicate PC-specific expression of Lama2 and show a decline of PCs and Lama2 in <italic>Pdg</italic>fb<sup>ret/ret</sup> mice. Boxed areas represent high-magnification images.</p><p>(F) Fluorescence images of oligodendrocytes (Olig2+/MBP+) 2 DIV with control medium, PC-CM with IgG, and PC-CM with anti-Lama2-blocking antibody.</p><p>(G) Graph displaying the percentage of Olig2+/MBP+ cells.</p><p>(H) Fluorescence images of OPCs in control medium, PC- CM from non-targeting siRNA, and PC Lama2 siRNA-treated-CM.</p><p>(I) Graph displaying the Olig2+/MBP+ cell population in the presence of the different siRNA-treated PC-CMs. n&#x000a0;= 4 mice per group, and 3 or more independent cell preparations were used, except for siRNA experiments, where n&#x000a0;= 2.</p><p>Means &#x000b1; SEM are shown. Data were analyzed by Student&#x02019;s t test or one-way ANOVA followed by Tukey&#x02019;s post hoc test. <sup>&#x02217;</sup>p&#x000a0;&#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.01, <sup>&#x02217;&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.001. Scale bars, (C) 5&#x000a0;&#x003bc;m; (D) 100&#x000a0;&#x003bc;m, high-magnification 10&#x000a0;&#x003bc;m; (E) and (G), 50&#x000a0;&#x003bc;m.</p></caption><graphic xlink:href="gr4"/></fig></p></sec></sec><sec id="sec3"><title>Discussion</title><p>This work reveals an unidentified role of PCs in CNS regeneration. We show that PCs in the vessel walls respond to demyelination by proliferation. We describe a parenchymal cell population expressing PC markers such as PDGFRb and desmin that appears soon after the induction of demyelination. Although these cells express PC markers, we cannot be certain of their origin, and, therefore, we refer to them as PLCs. Upon demyelination, both PCs and PLCs have a high proliferative response; however, mature oligodendrocytes are preferentially located in higher frequency close to PCs. These data suggest that, even though both populations respond to demyelination, they may have differential roles in their interaction with OPCs during remyelination, which will require further investigation. In mice with a reduced PC density, OPC differentiation is delayed in the demyelinated lesion, resulting in fewer mature oligodendrocytes at 14 dpl. Moreover, exposure to PC-CM accelerated OPC differentiation and enhanced ex&#x000a0;vivo remyelination. We identified Lama2 as a key factor responsible for the effect of PCs in promoting OPC differentiation.</p><p>In humans, loss of <italic>LAMA2</italic> gene expression causes WM abnormalities, manifested at an early postnatal age, when developmental myelination occurs (<xref rid="bib1" ref-type="bibr">Allamand and Guicheney, 2002</xref>). Similarly, a mouse model for Lama2 deficiency (<italic>Lama2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>) shows developmental delays in oligodendrocyte differentiation and the accumulation of OPCs, leading to defects in myelination in the corpus callosum (<xref rid="bib6" ref-type="bibr">Chun et&#x000a0;al., 2003</xref>, <xref rid="bib23" ref-type="bibr">Relucio et&#x000a0;al., 2012</xref>). Lama2 regulates OPC function through its interaction with dystroglycan (<xref rid="bib16" ref-type="bibr">Leiton et&#x000a0;al., 2015</xref>). In the CNS, Lama2 is expressed by PCs and upregulated during OPC differentiation (14 dpl) in a toxin-induced demyelination model (<xref rid="bib31" ref-type="bibr">Zhao et&#x000a0;al., 2009</xref>). Lama2 seems to be relevant for PC function because <italic>Lama2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice have decreased microvascular PC coverage associated with BBB defects (<xref rid="bib21" ref-type="bibr">Menezes et&#x000a0;al., 2014</xref>). Our data suggest that PC-derived Lama2 has a key role in promoting OPC differentiation because the PC-CM effect in OPCs was inhibited when exposed to an anti-Lama2 antibody or when PCs were treated with Lama2 siRNA. Consistent with this, we observed that OPC differentiation was delayed in adult <italic>Pdgfb</italic><sup>ret/ret</sup> mice after lysolecithin-induced demyelination. These findings indicate that PCs provide an appropriate milieu for differentiating OPCs through Lama2.</p><p>This study indicates that PC functions are not restricted to vascular homeostasis but, rather, extend to CNS regeneration. This is supported by studies illustrating that PCs respond with high proliferation to acute lesions such as stroke or spinal cord injury (SCI), where they modulate inflammation or the formation of fibrotic scar tissue (<xref rid="bib12" ref-type="bibr">G&#x000f6;ritz et&#x000a0;al., 2011</xref>, <xref rid="bib22" ref-type="bibr">&#x000d6;zen et&#x000a0;al., 2014</xref>). Here we show that, besides stabilizing CNS vasculature and regulating EC function, pericytes also have a high proliferative response following CNS demyelination and directly influence CNS-resident progenitor cell differentiation during remyelination, most likely by secretion of Lama2.</p></sec><sec id="sec4"><title>Experimental Procedures</title><sec id="sec4.1"><title>Animal Work</title><p>Animal experiments within this research have been regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the University of Cambridge Animal Welfare and&#x000a0;Ethical Review Body (AWERB) in accordance with United Kingdom Home Office regulations (Project License 70/7715) and in accordance with Austrian laws on animal experimentation and were approved by Austrian regulatory authorities (Permit No. BMWF-66.012/0001-II/3b/2014; license codes BMBF-66-012/0037-WF/V/3b/2014 and BMWF-66.012/0032-WF/V/3b/2015). During this study, 2-&#x000a0;to 3-month-old Sprague Dawley rats and 12-week-old <italic>Pdgfb</italic>ret/ret mice (hetero- and homozygous), which were previously described by <xref rid="bib2" ref-type="bibr">Armulik et&#x000a0;al. (2010)</xref> and <xref rid="bib17" ref-type="bibr">Lindblom et&#x000a0;al. (2003)</xref>, were used for toxin-induced demyelination.</p></sec><sec id="sec4.2"><title>Cell Culture</title><p>Preparation of CNS pericytes was performed following the Dore-Duffy protocol (<xref rid="bib8" ref-type="bibr">Dore-Duffy et&#x000a0;al., 2006</xref>) with modifications. Rat bone marrow-derived MSCs were prepared as described previously by <xref rid="bib24" ref-type="bibr">Rivera et&#x000a0;al. (2006)</xref>. OPCs were prepared from neonatal P0&#x02013;P2 Sprague-Dawley rats, cortices and hippocampi were digested with papain solution, and dissociated cells were seeded into poly-D-lysine-coated T75 flasks. Mixed glial cultures were kept for 11 DIV in medium with DMEM (Gibco) and 10% fetal bovine serum (Biosera). OPCs were isolated as described previously (<xref rid="bib20" ref-type="bibr">McCarthy and de Vellis, 1980</xref>).</p></sec><sec id="sec4.3"><title>Organotypic Cerebellar Slices</title><p>Remyelination of rat cerebellar slices was prepared as described previously (<xref rid="bib3" ref-type="bibr">Birgbauer et&#x000a0;al., 2004</xref>). After 7 DIV, the medium was replaced with organotypic slice medium containing 0.5&#x000a0;mg/mL lysolecithin for 16&#x000a0;hr. After 16&#x000a0;hr, the medium was replaced with PC-conditioned organotypic slice medium and non-conditioned control medium.</p></sec><sec id="sec4.4"><title>Statistical Analyses</title><p>Graphs show mean values &#x000b1; SEM, and statistical analysis were performed using GraphPad Prism 5.0 (GraphPad) and SPSS 20 (IBM). Parametric one-way ANOVA, Tukey post hoc analyses, Student&#x02019;s t test, or Mann-Whitney <italic>U</italic>&#x000a0;tests (when not normally distributed) were used when comparing one parameter. For statistical analysis with two parameters, such as time course experiments with different treatments, two-way ANOVA with Bonferroni post hoc was used. For distance frequency distribution analysis, chi-square test was used (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>M; <xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref>G and S1H). All experiments were performed as indicated by n in the figure legends. Significance was as follows: p<sup>&#x02217;</sup>&#x000a0;&#x0003c; 0.05, p<sup>&#x02217;&#x02217;</sup>&#x000a0;&#x0003c; 0.01, and p<sup>&#x02217;&#x02217;&#x02217;</sup>&#x000a0;&#x0003c; 0.001.</p><p>For further details, see the <xref rid="mmc1" ref-type="supplementary-material">Supplemental Experimental Procedures</xref>.</p></sec></sec><sec id="sec5"><title>Author Contributions</title><p>S.L. and F.J.R. conceived the project. A.G.D.L.F., S.L., L.A., R.J.M.F., and F.J.R. designed the study. S.L., A.G.D.L.F., L.F.B., C.B., L.A., R.J.M.F., and F.J.R. wrote and edited the manuscript. S.L. and A.G.D.L.F. designed the figures. A.G.D.L.F., S.L., H.T., C.Z., A.K., G.A.G., L.D.C., M.A.M., J.A., C.B., R.J.M.F., L.A., and F.J.R. planned the experiments. A.G.D.L.F., S.L., M.E.S., P.v.W., P.R., O.E., C.Z., G.A.G., A.K., M.A.M., J.A., and L.D.C. conducted the experiments. A.G.D.L.F., S.L., M.E.S., H.T., A.T., P.R., A.O., L.B., A.K., M.A.M., J.A., and F.J.R. collected data. A.G.D.L.F., S.L., M.E.S., G.A.G., L.D.C., C.Z., P.R., A.T., L.H., A.K., M.A.M., and J.A. analyzed data. A.G.D.L.F., S.L., P.R., G.A.G., A.K., M.A.M., J.A., C.B., R.J.M.F., L.A., and F.J.R. interpreted data. H.T., A.T., P.R., A.O., P.Z., S.C.D., and L.B. assisted technically. R.J.M.F., L.A., and F.J.R. supervised the project. C.B., L.A., R.J.M.F., and F.J.R. supported this study financially.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Allamand</surname><given-names>V.</given-names></name><name><surname>Guicheney</surname><given-names>P.</given-names></name></person-group><article-title>Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin)</article-title><source>Eur. J. Hum. Genet.</source><volume>10</volume><year>2002</year><fpage>91</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">11938437</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Armulik</surname><given-names>A.</given-names></name><name><surname>Genov&#x000e9;</surname><given-names>G.</given-names></name><name><surname>M&#x000e4;e</surname><given-names>M.</given-names></name><name><surname>Nisancioglu</surname><given-names>M.H.</given-names></name><name><surname>Wallgard</surname><given-names>E.</given-names></name><name><surname>Niaudet</surname><given-names>C.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Norlin</surname><given-names>J.</given-names></name><name><surname>Lindblom</surname><given-names>P.</given-names></name><name><surname>Strittmatter</surname><given-names>K.</given-names></name></person-group><article-title>Pericytes regulate the blood-brain barrier</article-title><source>Nature</source><volume>468</volume><year>2010</year><fpage>557</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">20944627</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Birgbauer</surname><given-names>E.</given-names></name><name><surname>Rao</surname><given-names>T.S.</given-names></name><name><surname>Webb</surname><given-names>M.</given-names></name></person-group><article-title>Lysolecithin induces demyelination in&#x000a0;vitro in a cerebellar slice culture system</article-title><source>J.&#x000a0;Neurosci. Res.</source><volume>78</volume><year>2004</year><fpage>157</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">15378614</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.W.</given-names></name><name><surname>Montelatici</surname><given-names>E.</given-names></name><name><surname>Crisan</surname><given-names>M.</given-names></name><name><surname>Corselli</surname><given-names>M.</given-names></name><name><surname>Huard</surname><given-names>J.</given-names></name><name><surname>Lazzari</surname><given-names>L.</given-names></name><name><surname>P&#x000e9;ault</surname><given-names>B.</given-names></name></person-group><article-title>Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both?</article-title><source>Cytokine Growth Factor Rev.</source><volume>20</volume><year>2009</year><fpage>429</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">19926515</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Choe</surname><given-names>Y.</given-names></name><name><surname>Huynh</surname><given-names>T.</given-names></name><name><surname>Pleasure</surname><given-names>S.J.</given-names></name></person-group><article-title>Migration of oligodendrocyte progenitor cells is controlled by transforming growth factor &#x003b2; family proteins during corticogenesis</article-title><source>J.&#x000a0;Neurosci.</source><volume>34</volume><year>2014</year><fpage>14973</fpage><lpage>14983</lpage><pub-id pub-id-type="pmid">25378163</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>S.J.</given-names></name><name><surname>Rasband</surname><given-names>M.N.</given-names></name><name><surname>Sidman</surname><given-names>R.L.</given-names></name><name><surname>Habib</surname><given-names>A.A.</given-names></name><name><surname>Vartanian</surname><given-names>T.</given-names></name></person-group><article-title>Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination</article-title><source>J.&#x000a0;Cell Biol.</source><volume>163</volume><year>2003</year><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">14581460</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Crisan</surname><given-names>M.</given-names></name><name><surname>Yap</surname><given-names>S.</given-names></name><name><surname>Casteilla</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>C.W.</given-names></name><name><surname>Corselli</surname><given-names>M.</given-names></name><name><surname>Park</surname><given-names>T.S.</given-names></name><name><surname>Andriolo</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Zheng</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name></person-group><article-title>A perivascular origin for mesenchymal stem cells in multiple human organs</article-title><source>Cell Stem Cell</source><volume>3</volume><year>2008</year><fpage>301</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">18786417</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Dore-Duffy</surname><given-names>P.</given-names></name><name><surname>Katychev</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Van Buren</surname><given-names>E.</given-names></name></person-group><article-title>CNS microvascular pericytes exhibit multipotential stem cell activity</article-title><source>J.&#x000a0;Cereb. Blood Flow Metab.</source><volume>26</volume><year>2006</year><fpage>613</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">16421511</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>R.J.</given-names></name><name><surname>Ffrench-Constant</surname><given-names>C.</given-names></name></person-group><article-title>Remyelination in the CNS: from biology to therapy</article-title><source>Nat. Rev. Neurosci.</source><volume>9</volume><year>2008</year><fpage>839</fpage><lpage>855</lpage><pub-id pub-id-type="pmid">18931697</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>R.J.</given-names></name><name><surname>Ffrench-Constant</surname><given-names>C.</given-names></name><name><surname>Edgar</surname><given-names>J.M.</given-names></name><name><surname>Smith</surname><given-names>K.J.</given-names></name></person-group><article-title>Neuroprotection and repair in multiple sclerosis</article-title><source>Nat. Rev. Neurol.</source><volume>8</volume><year>2012</year><fpage>624</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">23026979</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Goldschmidt</surname><given-names>T.</given-names></name><name><surname>Antel</surname><given-names>J.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>F.B.</given-names></name><name><surname>Br&#x000fc;ck</surname><given-names>W.</given-names></name><name><surname>Kuhlmann</surname><given-names>T.</given-names></name></person-group><article-title>Remyelination capacity of the MS brain decreases with disease chronicity</article-title><source>Neurology</source><volume>72</volume><year>2009</year><fpage>1914</fpage><lpage>1921</lpage><pub-id pub-id-type="pmid">19487649</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>G&#x000f6;ritz</surname><given-names>C.</given-names></name><name><surname>Dias</surname><given-names>D.O.</given-names></name><name><surname>Tomilin</surname><given-names>N.</given-names></name><name><surname>Barbacid</surname><given-names>M.</given-names></name><name><surname>Shupliakov</surname><given-names>O.</given-names></name><name><surname>Fris&#x000e9;n</surname><given-names>J.</given-names></name></person-group><article-title>A pericyte origin of spinal cord scar tissue</article-title><source>Science</source><volume>333</volume><year>2011</year><fpage>238</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">21737741</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Vanlandewijck</surname><given-names>M.</given-names></name><name><surname>Raschperger</surname><given-names>E.</given-names></name><name><surname>Andaloussi M&#x000e4;e</surname><given-names>M.</given-names></name><name><surname>Jung</surname><given-names>B.</given-names></name><name><surname>Lebouvier</surname><given-names>T.</given-names></name><name><surname>Ando</surname><given-names>K.</given-names></name><name><surname>Hofmann</surname><given-names>J.</given-names></name><name><surname>Keller</surname><given-names>A.</given-names></name><name><surname>Betsholtz</surname><given-names>C.</given-names></name></person-group><article-title>Analysis of the brain mural cell transcriptome</article-title><source>Sci. Rep.</source><volume>6</volume><year>2016</year><fpage>35108</fpage><pub-id pub-id-type="pmid">27725773</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Jadasz</surname><given-names>J.J.</given-names></name><name><surname>Kremer</surname><given-names>D.</given-names></name><name><surname>G&#x000f6;ttle</surname><given-names>P.</given-names></name><name><surname>Tzekova</surname><given-names>N.</given-names></name><name><surname>Domke</surname><given-names>J.</given-names></name><name><surname>Rivera</surname><given-names>F.J.</given-names></name><name><surname>Adjaye</surname><given-names>J.</given-names></name><name><surname>Hartung</surname><given-names>H.P.</given-names></name><name><surname>Aigner</surname><given-names>L.</given-names></name><name><surname>K&#x000fc;ry</surname><given-names>P.</given-names></name></person-group><article-title>Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation</article-title><source>PLoS ONE</source><volume>8</volume><year>2013</year><fpage>e71814</fpage><pub-id pub-id-type="pmid">23951248</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>S.</given-names></name><name><surname>Trost</surname><given-names>A.</given-names></name><name><surname>Tempfer</surname><given-names>H.</given-names></name><name><surname>Bauer</surname><given-names>H.C.</given-names></name><name><surname>Bauer</surname><given-names>H.</given-names></name><name><surname>Rohde</surname><given-names>E.</given-names></name><name><surname>Reitsamer</surname><given-names>H.A.</given-names></name><name><surname>Franklin</surname><given-names>R.J.</given-names></name><name><surname>Aigner</surname><given-names>L.</given-names></name><name><surname>Rivera</surname><given-names>F.J.</given-names></name></person-group><article-title>Brain pericyte plasticity as a potential drug target in CNS repair</article-title><source>Drug Discov. Today</source><volume>18</volume><year>2013</year><fpage>456</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">23266366</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Leiton</surname><given-names>C.V.</given-names></name><name><surname>Aranmolate</surname><given-names>A.</given-names></name><name><surname>Eyermann</surname><given-names>C.</given-names></name><name><surname>Menezes</surname><given-names>M.J.</given-names></name><name><surname>Escobar-Hoyos</surname><given-names>L.F.</given-names></name><name><surname>Husain</surname><given-names>S.</given-names></name><name><surname>Winder</surname><given-names>S.J.</given-names></name><name><surname>Colognato</surname><given-names>H.</given-names></name></person-group><article-title>Laminin promotes metalloproteinase-mediated dystroglycan processing to regulate oligodendrocyte progenitor cell proliferation</article-title><source>J.&#x000a0;Neurochem.</source><volume>135</volume><year>2015</year><fpage>522</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">26171643</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Lindblom</surname><given-names>P.</given-names></name><name><surname>Gerhardt</surname><given-names>H.</given-names></name><name><surname>Liebner</surname><given-names>S.</given-names></name><name><surname>Abramsson</surname><given-names>A.</given-names></name><name><surname>Enge</surname><given-names>M.</given-names></name><name><surname>Hellstrom</surname><given-names>M.</given-names></name><name><surname>Backstrom</surname><given-names>G.</given-names></name><name><surname>Fredriksson</surname><given-names>S.</given-names></name><name><surname>Landegren</surname><given-names>U.</given-names></name><name><surname>Nystrom</surname><given-names>H.C.</given-names></name></person-group><article-title>Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall</article-title><source>Genes Dev.</source><volume>17</volume><year>2003</year><fpage>1835</fpage><lpage>1840</lpage><pub-id pub-id-type="pmid">12897053</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Maki</surname><given-names>T.</given-names></name><name><surname>Maeda</surname><given-names>M.</given-names></name><name><surname>Uemura</surname><given-names>M.</given-names></name><name><surname>Lo</surname><given-names>E.K.</given-names></name><name><surname>Terasaki</surname><given-names>Y.</given-names></name><name><surname>Liang</surname><given-names>A.C.</given-names></name><name><surname>Shindo</surname><given-names>A.</given-names></name><name><surname>Choi</surname><given-names>Y.K.</given-names></name><name><surname>Taguchi</surname><given-names>A.</given-names></name><name><surname>Matsuyama</surname><given-names>T.</given-names></name></person-group><article-title>Potential interactions between pericytes and oligodendrocyte precursor cells in perivascular regions of cerebral white matter</article-title><source>Neurosci. Lett.</source><volume>597</volume><year>2015</year><fpage>164</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">25936593</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Manavski</surname><given-names>Y.</given-names></name><name><surname>Boon</surname><given-names>R.A.</given-names></name><name><surname>Dimmeler</surname><given-names>S.</given-names></name></person-group><article-title>Vascular niche controls organ regeneration</article-title><source>Circ. Res.</source><volume>114</volume><year>2014</year><fpage>1077</fpage><lpage>1079</lpage><pub-id pub-id-type="pmid">24677233</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>K.D.</given-names></name><name><surname>de Vellis</surname><given-names>J.</given-names></name></person-group><article-title>Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue</article-title><source>J.&#x000a0;Cell Biol.</source><volume>85</volume><year>1980</year><fpage>890</fpage><lpage>902</lpage><pub-id pub-id-type="pmid">6248568</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Menezes</surname><given-names>M.J.</given-names></name><name><surname>McClenahan</surname><given-names>F.K.</given-names></name><name><surname>Leiton</surname><given-names>C.V.</given-names></name><name><surname>Aranmolate</surname><given-names>A.</given-names></name><name><surname>Shan</surname><given-names>X.</given-names></name><name><surname>Colognato</surname><given-names>H.</given-names></name></person-group><article-title>The extracellular matrix protein laminin &#x003b1;2 regulates the maturation and function of the blood-brain barrier</article-title><source>J.&#x000a0;Neurosci.</source><volume>34</volume><year>2014</year><fpage>15260</fpage><lpage>15280</lpage><pub-id pub-id-type="pmid">25392494</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>&#x000d6;zen</surname><given-names>I.</given-names></name><name><surname>Deierborg</surname><given-names>T.</given-names></name><name><surname>Miharada</surname><given-names>K.</given-names></name><name><surname>Padel</surname><given-names>T.</given-names></name><name><surname>Englund</surname><given-names>E.</given-names></name><name><surname>Genov&#x000e9;</surname><given-names>G.</given-names></name><name><surname>Paul</surname><given-names>G.</given-names></name></person-group><article-title>Brain pericytes acquire a microglial phenotype after stroke</article-title><source>Acta Neuropathol.</source><volume>128</volume><year>2014</year><fpage>381</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">24848101</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Relucio</surname><given-names>J.</given-names></name><name><surname>Menezes</surname><given-names>M.J.</given-names></name><name><surname>Miyagoe-Suzuki</surname><given-names>Y.</given-names></name><name><surname>Takeda</surname><given-names>S.</given-names></name><name><surname>Colognato</surname><given-names>H.</given-names></name></person-group><article-title>Laminin regulates postnatal oligodendrocyte production by promoting oligodendrocyte progenitor survival in the subventricular zone</article-title><source>Glia</source><volume>60</volume><year>2012</year><fpage>1451</fpage><lpage>1467</lpage><pub-id pub-id-type="pmid">22706957</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>F.J.</given-names></name><name><surname>Couillard-Despres</surname><given-names>S.</given-names></name><name><surname>Pedre</surname><given-names>X.</given-names></name><name><surname>Ploetz</surname><given-names>S.</given-names></name><name><surname>Caioni</surname><given-names>M.</given-names></name><name><surname>Lois</surname><given-names>C.</given-names></name><name><surname>Bogdahn</surname><given-names>U.</given-names></name><name><surname>Aigner</surname><given-names>L.</given-names></name></person-group><article-title>Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells</article-title><source>Stem Cells</source><volume>24</volume><year>2006</year><fpage>2209</fpage><lpage>2219</lpage><pub-id pub-id-type="pmid">16763198</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>H.H.</given-names></name><name><surname>Niu</surname><given-names>J.</given-names></name><name><surname>Munji</surname><given-names>R.</given-names></name><name><surname>Davalos</surname><given-names>D.</given-names></name><name><surname>Chang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Tien</surname><given-names>A.C.</given-names></name><name><surname>Kuo</surname><given-names>C.J.</given-names></name><name><surname>Chan</surname><given-names>J.R.</given-names></name><name><surname>Daneman</surname><given-names>R.</given-names></name><name><surname>Fancy</surname><given-names>S.P.</given-names></name></person-group><article-title>Oligodendrocyte precursors migrate along vasculature in the developing nervous system</article-title><source>Science</source><volume>351</volume><year>2016</year><fpage>379</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">26798014</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Winkler</surname><given-names>E.A.</given-names></name><name><surname>Bell</surname><given-names>R.D.</given-names></name><name><surname>Zlokovic</surname><given-names>B.V.</given-names></name></person-group><article-title>Central nervous system pericytes in health and disease</article-title><source>Nat. Neurosci.</source><volume>14</volume><year>2011</year><fpage>1398</fpage><lpage>1405</lpage><pub-id pub-id-type="pmid">22030551</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>T.J.</given-names></name><name><surname>Johnson</surname><given-names>K.R.</given-names></name><name><surname>Miron</surname><given-names>V.E.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Quandt</surname><given-names>J.</given-names></name><name><surname>Harrisingh</surname><given-names>M.C.</given-names></name><name><surname>Swire</surname><given-names>M.</given-names></name><name><surname>Williams</surname><given-names>A.</given-names></name><name><surname>McFarland</surname><given-names>H.F.</given-names></name><name><surname>Franklin</surname><given-names>R.J.</given-names></name><name><surname>Ffrench-Constant</surname><given-names>C.</given-names></name></person-group><article-title>Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination</article-title><source>Brain</source><volume>136</volume><year>2013</year><fpage>1035</fpage><lpage>1047</lpage><pub-id pub-id-type="pmid">23518706</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>T.J.</given-names></name><name><surname>Silbereis</surname><given-names>J.C.</given-names></name><name><surname>Griveau</surname><given-names>A.</given-names></name><name><surname>Chang</surname><given-names>S.M.</given-names></name><name><surname>Daneman</surname><given-names>R.</given-names></name><name><surname>Fancy</surname><given-names>S.P.</given-names></name><name><surname>Zahed</surname><given-names>H.</given-names></name><name><surname>Maltepe</surname><given-names>E.</given-names></name><name><surname>Rowitch</surname><given-names>D.H.</given-names></name></person-group><article-title>Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis</article-title><source>Cell</source><volume>158</volume><year>2014</year><fpage>383</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">25018103</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Zawadzka</surname><given-names>M.</given-names></name><name><surname>Rivers</surname><given-names>L.E.</given-names></name><name><surname>Fancy</surname><given-names>S.P.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Tripathi</surname><given-names>R.</given-names></name><name><surname>Jamen</surname><given-names>F.</given-names></name><name><surname>Young</surname><given-names>K.</given-names></name><name><surname>Goncharevich</surname><given-names>A.</given-names></name><name><surname>Pohl</surname><given-names>H.</given-names></name><name><surname>Rizzi</surname><given-names>M.</given-names></name></person-group><article-title>CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination</article-title><source>Cell Stem Cell</source><volume>6</volume><year>2010</year><fpage>578</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">20569695</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Jarjour</surname><given-names>A.A.</given-names></name><name><surname>Boyd</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>A.</given-names></name></person-group><article-title>Central nervous system remyelination in culture--a tool for multiple sclerosis research</article-title><source>Exp. Neurol.</source><volume>230</volume><year>2011</year><fpage>138</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">21515259</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Fancy</surname><given-names>S.P.</given-names></name><name><surname>Franklin</surname><given-names>R.J.</given-names></name><name><surname>Ffrench-Constant</surname><given-names>C.</given-names></name></person-group><article-title>Up-regulation&#x000a0;of oligodendrocyte precursor cell alphaV integrin and its extracellular ligands during central nervous system remyelination</article-title><source>J.&#x000a0;Neurosci. Res.</source><volume>87</volume><year>2009</year><fpage>3447</fpage><lpage>3455</lpage><pub-id pub-id-type="pmid">19739252</pub-id></element-citation></ref></ref-list><sec id="app2" sec-type="supplementary-material"><title>Supplemental Information</title><p><supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Supplemental Experimental Procedures and Figures S1&#x02013;S4</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material><supplementary-material content-type="local-data" id="mmc2"><caption><title>Document S2. Article plus Supplemental Information</title></caption><media xlink:href="mmc2.pdf"/></supplementary-material></p></sec><ack id="ack0010"><title>Acknowledgments</title><p>We thank Hannelore Bauer, Peter Hammerl, and Andreas Traweger for technical advice and support. This work was supported by research funds from Chilean <funding-source id="gs1">FONDECYT Program CONICYT</funding-source> Grants 1161787 (to F.J.R.) and 1141015 (to L.F.B); <funding-source id="gs2">Direccion de Investigaci&#x000f3;n y Desarrollo-Universidad Austral de Chile (DID-UACh)</funding-source>; <funding-source id="gs3">Paracelsus Medical University PMU-FFF</funding-source> Long-Term Fellowship L-12/01/001-RIV (to F.J.R.) and Stand-Alone Grant E-12/15/077-RIT (to F.J.R. and A.T.); the <funding-source id="gs4">European Union Seventh Framework Program</funding-source> (FP7/2007-2013) under Grant Agreements HEALTH-F2-2011-278850 (INMiND), HEALTH-F2-2011-279288 (IDEA), and FP7-REGPOT-316120 (GlowBrain); <funding-source id="gs5">Austrian Science Fund FWF Special Research Program (SFB) F44</funding-source> (F4413-B23) &#x0201c;Cell Signaling in Chronic CNS Disorders&#x0201d;; and <funding-source id="gs6">State Government of Salzburg, Austria</funding-source> (Stiftungsprofessur and 20204-WISS/80/199-2014). In addition, this study was supported by grants from a core support grant from the <funding-source id="gs7">Wellcome Trust</funding-source> (203151/Z/16/Z) and <funding-source id="gs8">MRC</funding-source> to the Wellcome Trust&#x02013;Medical Research Council Cambridge Stem Cell Institute, the <funding-source id="gs9">UK Multiple Sclerosis Society</funding-source> (941/11), the <funding-source id="gs10">David and Isobel Walker Trust</funding-source>, <funding-source id="gs11">&#x0201c;Investissements d&#x02019;avenir&#x0201d; IHU-A-ICM</funding-source> and <funding-source id="gs12">Obra Social La Caixa</funding-source>, the <funding-source id="gs13">Swedish Science Council</funding-source> (2015-00550), the <funding-source id="gs14">Swedish Cancer Foundation</funding-source> (15 0735), the <funding-source id="gs15">Knut and Alice Wallenberg Foundation</funding-source> (2015.0030), the <funding-source id="gs16">European Research Council</funding-source>&#x000a0;(AdG 294556 BBBARRIER), and the <funding-source id="gs17">Leducq Foundation (Sphingonet</funding-source>; 14CVD02). P.v.W. was supported by <funding-source id="gs18">National Health &#x00026; Medical Research&#x000a0;Council of Australia</funding-source> Early Career Fellowship 628928. Work in A.K.&#x02019;s group was funded by the <funding-source id="gs19">Swiss National Science Foundation</funding-source> (31003A_159514/1; <ext-link ext-link-type="uri" xlink:href="http://www.snf.ch/en" id="intref0010">http://www.snf.ch/en</ext-link>) and <funding-source id="gs20">The Synapsis Foundation</funding-source> (<ext-link ext-link-type="uri" xlink:href="http://www.alzheimer-synapsis.ch/" id="intref0015">http://www.alzheimer-synapsis.ch</ext-link>).</p></ack><fn-group><fn id="app1" fn-type="supplementary-material"><p>Supplemental Information includes Supplemental Experimental Procedures and four figures and can be found with this article online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.celrep.2017.08.007" id="intref0020">http://dx.doi.org/10.1016/j.celrep.2017.08.007</ext-link>.</p></fn></fn-group></back></article>